|
Microbiology Education Series - Mycology No.1 |
|
Candida albicans |
This web text will specifically focus on Candida albicans but may briefly reference other Candida species.
1
Background / History
- Candida albicans, (yeast) accounts for up to 90% of superficial candidosis which can involve the nails and skin plus the mucous membranes of the mouth and vagina.
- There are a number of other species of Candida which also cause superficial candidosis but they will not be covered in detail in this text.
- C. albicans is a commensal and can be seen along with other commensal flora of the vagina, mouth, skin and gastrointestinal tract, etc.
- As a person gets older the carriage rate of C. albicans normally increases and the incidence of patients with Candida in hospital is higher than the incidence of persons in the general population.
- Pregnant woman also show a higher incidence of candidosis owing to their lowered immunity during pregnancy.
- A patient who has contracted a disease which may have lowered their immunity can cause the C. albicans to become an opportunistic pathogen.
- Uncontrolled and indiscriminate use of antibiotics which alter the body's normal flora can directly lead to overgrowth of yeast.
2
Classification
Classification
C. albicans
Kingdom Fungi
Phylum Ascomycota
Subphylum Saccharomycotina
Class Saccharomycetes
Order Saccharomycetales
Family Saccharomycetaceae
Genus Candida
Species Candida albicans
3
Morphology
- Morphology of C. albicans can be; Yeast like, filamentous or it can produce pseudohyphae, ( elongated cells linked together ). See Fig.1.
- Pseudohyphal formation is a type of budding where hypahe elongate and remain attached to the mother cell.
- Dimorphic - C. albicans can exist in either a mycelial state or a yeast state depending on growth conditions.
Fig.1 Gram stained Candida albicans (yeast)
REPLICATION
- All fungi reproduce by asexual mechanisms but not all fungi reproduce sexually;
a) Anamorph - fungal asexual reproduction
b) Telomorph - fungal sexual reproduction
- The above terms a and b are mainly used for classification purposes, for example, the organism is given different names depending on whether it is in an Anamorphic state phase or a telomorphic phase. This ruling applies to all fungal organisms including C. albicans.
- Clinically, fungal organisms are referred to by their anamorphic state name.
4
Pathogenesis
IMMUNITY
- Innate Immunity - Evidence suggests that the body has a strong innate immunity to C. albicans infections especially in healthy individuals.
- Humoral / Cell mediated immunity - these are two processes that are also responsible for immune protection against Candida infection. Cell mediated immunity is generally more important than other immune defence mechanisms against C. albicans.
- Serum antibody - The human host produces antibody to the cell wall of C. albicans
5
Clinical Disease
- As well as C. albicans, other Candida species are responsible for localised skin and nail disease
- Mucosal infection sites - Skin, mouth, vagina, bronchi within the lungs and the oesophagus.
- Below is a list of sites that can become infected with C. albicans plus a list of resulting diseases.
SYSTEMIC
Pulmonary infection, endocarditis, UTI, Endopthalmitis, menningitis
CUTANEOUS
Paronchia, onycomycosis
MUCOCUTANEOUS
Thrush, perianal disease
CHRONIC
Granulomatous diease, mucocutaneous candidiasis.
- Some causes of C. albicans infections are as follows;
a) Immunosupression - diabetes melitus, burns, intravascular catheter, IVDA's
b) Mechanical - Occlusion, trauma
c) Other - AIDS, pregnancy, unchecked use of broad spectrum antibiotics.
6
Epidemiology
- It is well documented that Candida albicans is still the most frequent cause of candidiasis.
- Candida albicans serotype A is more prevalent that serotype B in clinical isolates. However the relative percentages of each serotype may vary according to geographical location.
- Resistance - Candida albicans serotype A is susceptible to 5-fluorocystosine whereas, serotype B can show resistance.
7
Laboratory Diagnosis
- For the purposes of this text c. albicans is the organism of focus. However, it is important to note that there are a number of other Candida species also responsible for causing infection, for example, C. tropicalis, C. glabrata, C. kefyr and C. parapsilopsis.
- C. albicans - as previously mentioned may present itself in different forms including budding yeasts, pseudohyphae and septatehyphae.
- Culture - C. albicans produces yeast and pseudohypael cells on culture media.
- Colony appearance - In general colonies appear cream coloured, pasty and opaque.
Fig.2. Colonial growth of Candida albicans on:
a) blood agar
b) Sabouraud's agar
- Sample type - many types of sample can be used to screen for C. albicans including, CSF, Surgical specimens and blood, ( sterile sites ), and urine and sputum, ( non sterile sites ).
- Identification - A combination of microscopy and biochemical tests are used to identify C. albicans.
- Germ Tube Test - some C. albicans blastospores produce hyphae or germ tubes when incubated at 37oC in serum (see Fig.3). The test has to be read within 3 hours owing to the fact that other Candida species may also produce germ tubes with longer incubation periods.
Fig. 3. Germ tube formation from a single Candida albicans cell
- Biochemical tests - Some C. albicans isolates fail to produce germ tubes using the germ tube test so biochemical tests have to be employed.
Product
Product Code
Description
Details
Sabouraud's agars and broths Various according to formula - see details
For the selective cultivation and isolation of yeasts including C. albicans
Columbia agar CB2/1229
For the cultivation of fastidious microorganisms and for general use Defibrinated horse blood Various according to volume - see details
An additive for the enrichment of microrganisms Lactophenol blue CB28/363060
For the staining and microscopic identification of fungi Lactophenol (Ammand) stain CB28/320600
For the staining and microscopic identification of fungi Gram's stain (Hucker) CB28/361520-0000
For Gram staining microorganisms. Ideal for automated staining machines Microscope slides Various according to type - see details
For mounting microorganisms for microscopic examination Loops Various according to type - see details
For manipulating microorganisms during laboratory investigations Swabs Various according to type - see details
For manipulating microorganisms during laboratory investigations and collection of clinical samples
8
Prevention / Control
- Topical Treatment - This is normally recommended for mucocutaneous and cutaneous disease. Patients normally respond well if the course of treatment is finished.
- Systemic Treatment - depends on the infected organ plus the individuals immune status.
- Antigungal used to treat systemic C.albicans are;
a) Amphotericin B, ( on its own or combined with 5-fluorocytosine )
b) 5-fluorocytosine
c) Azole derivitives, 9 Ketoconazole and fluconazole )
- Azole derivitives - these are less toxic than Amphotericin B but once treatment is stopped the fungal infection may return.
- Immunocompromised patients - Such patients pose a particular problem as the cause of the immunosupression has to be tackled before the antifungal treatment can be successful.
9
References
David Greenwood., Richard C. B. Slack., John F. Peutherer., (2002). Medical Microbiology. Sixteenth Edition. Churchill Livingstone. 60: pp 568-588.
Patrick R. Murray,. Ken S. Rosenthal,. George S. Kobayashi,. Michael A. Pfaller. (2002). Medical Microbiology. Fourth Edition. Mosby. 70: pp 651-667.
Topley & Wilson,. ( Libero,. Ajelo,. Roderick J. Hay,. ). (1998 ). MICROBIOLOGY AND MICROBIAL INFECTIONS. Volume 4, MEDICAL MYCOLOGY. 23: PP 423-451.
10
Acknowledgements
We wish to offer our sincere thanks to the staff at the Microbiology Laboratory, The George Eliot Hospital in Nuneaton, Warks for their permission to use the image of Candida albicans on the Microbiology Education Series, ( MES ), Mycology card No.1.
Whilst the author has made every effort to check the validity of factual information in this text it is ultimately up to the reader to confirm factual points. Cosmos Biomedical Ltd can accept no legal responsibility for mis-information or misinterpritation of text and any consequences of this. However, we would be grateful to anyone that informs us of errors in the text which we would immediately check and make the appropriate corrections.
11
Disclaimer
The MES Scheme, which includes question cards and web text is both Copyrighted and Trademarked and should not be reproduced under any circumstances in any way and at any time now or in the future without the express permission of Cosmos Biomedical Ltd. Only persons registered by Cosmos Biomedical Ltd are legally allowed to participate in the MES Scheme.
12
Copyright
Universal Excellence